Company leader
Michael Sistenich
Chief Executive Officer
Enlitic
Michael Sistenich is chief executive and a director of Enlitic, an imaging AI company listed on the Australian Securities Exchange whose software standardizes and organizes medical images across hospital archives.
Investing and Drug Development
He has more than 25 years of experience across healthcare, artificial intelligence, life sciences and institutional investing. He was chief executive and a non-executive director of Nohla Therapeutics, where he led the development and financing of a clinical-stage cell therapy platform, and a non-executive director of Opthea, a drug developer listed in Australia and on Nasdaq.
From Chairman to Chief Executive at Enlitic
He joined the Enlitic board in November 2018 as non-executive chairman and later became chief executive. In April 2026 he also joined the board of Resonance Health as a non-executive director.